foxo4-dri human study Peptide Most people learn about senescent

There is a limit to the amount of medicine that can be delivered comfortably

Some patients may notice symptoms returning before their next scheduled injection, particularly if they have higher metabolic demands or ongoing neurological involvement

This article demonstrates the efficacy of tirzepatide for treatment of MASH

The SToMP-AD trial will test the geroscience hypothesis by investigating the impact of targeting cellular senescence, a secondary hallmark of aging, on AD pathogenesis and other biological aging hallmarks

Pentadecapeptide BPC-157 beneficially influences the healing of colon-colon anastamoses in rats

Effectual anticancer potentiality of loaded bee venom onto fungal chitosan nanoparticles